Mary Anne Land joined The George Institute for Global Health in 2010. Not even 12 months after completing her Masters in Public Health in her hometown of Wollongong NSW, she now finds herself completing an internship at The World Health Organization (WHO) in Geneva.
For some time, medical experts have relied on a commonly used marker to treat a patient’s risk of cardiovascular events such as heart attack or stroke. New research recently published in the British Medical Journal by The George Institute for Global Health has clearly shown that this widely used treatment in people with kidney disease is not effective.
More than 30 million people suffer a heart attack each year in india. For those living in rural regions such as Andhra Pradesh on the south eastern coastline of India, the rate of cardiovascular disease is particularly high and the development and implementation of effective, low-cost preventive and therapeutic strategies is a public health priority.